PET/MR Imaging in the Evaluation of Lymphomas and Post-Transplant Lymphoproliferative Disorder in Pediatric Patients
Lisa J States1, Pensiree Attaseth2, Sabah Servaes3
1Department of Radiology, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, 3401 Civic Center Boulevard, Philadelphia, PA 10104, USA.
Abstract:
Pediatric lymphoma (PL) is the third most common malignancy to affect children, seen in up to 15% of children, after leukemia and central nervous system tumors. SEER data from 1975 - 2019 has shown an increase in the incidence of childhood cancer including leukemia and lymphomas. Fortunately, there has been an increase if the 5-year overall survival of PL. 18F-Fluordeoxyglucose PET imaging plays an important role in the diagnosis, staging and response to therapy in pediatric lymphomas. This review will focus on the incorporation of PET/MR into the standard treatment of children with PL.
